share_log

Morgan Stanley Maintains Equal-Weight on Evelo Biosciences, Raises Price Target to $10

Benzinga ·  Jul 26, 2023 22:55

Morgan Stanley analyst Vikram Purohit maintains Evelo Biosciences (NASDAQ:EVLO) with a Equal-Weight and raises the price target from $2 to $10.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment